- Home
- JFU vs TLPH Comparison
JFU vs TLPH Comparison
Compare JFU & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFU
- TLPH
- Stock Information
- Founded
- JFU 2006
- TLPH 2005
- Country
- JFU China
- TLPH United States
- Employees
- JFU N/A
- TLPH N/A
- Industry
- JFU Finance: Consumer Services
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- JFU Finance
- TLPH Health Care
- Exchange
- JFU Nasdaq
- TLPH Nasdaq
- Market Cap
- JFU 58.2M
- TLPH 64.7M
- IPO Year
- JFU 2019
- TLPH 2011
- Fundamental
- Price
- JFU $4.55
- TLPH $1.34
- Analyst Decision
- JFU
- TLPH Strong Buy
- Analyst Count
- JFU 0
- TLPH 1
- Target Price
- JFU N/A
- TLPH $6.00
- AVG Volume (30 Days)
- JFU 7.5K
- TLPH 318.3K
- Earning Date
- JFU 12-09-2022
- TLPH 11-12-2025
- Dividend Yield
- JFU N/A
- TLPH N/A
- EPS Growth
- JFU 3110.57
- TLPH N/A
- EPS
- JFU 3.04
- TLPH N/A
- Revenue
- JFU $44,573,690.00
- TLPH $28,000.00
- Revenue This Year
- JFU N/A
- TLPH N/A
- Revenue Next Year
- JFU N/A
- TLPH $14,533.26
- P/E Ratio
- JFU $1.48
- TLPH N/A
- Revenue Growth
- JFU 8.19
- TLPH N/A
- 52 Week Low
- JFU $1.01
- TLPH $0.38
- 52 Week High
- JFU $5.88
- TLPH $1.45
- Technical
- Relative Strength Index (RSI)
- JFU 50.98
- TLPH 57.82
- Support Level
- JFU $4.45
- TLPH $1.01
- Resistance Level
- JFU $4.82
- TLPH $1.35
- Average True Range (ATR)
- JFU 0.26
- TLPH 0.11
- MACD
- JFU -0.12
- TLPH -0.01
- Stochastic Oscillator
- JFU 17.46
- TLPH 80.49
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.